Cost-effectiveness analysis of the Oncotype DX Breast Recurrence Score® test among node-negative early breast cancer patients in Japan
- DOI
- 10.1007/s12282-026-01834-7
- Published
- 2026-02-15
- Container
- Breast Cancer
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s12282-026-01834-7,
title = {Cost-effectiveness analysis of the Oncotype DX Breast Recurrence Score® test among node-negative early breast cancer patients in Japan},
author = {Kei Koizumi and Ataru Igarashi and Mark Gouldson and Sandeep Bilthare and Sebastien Eymere and Gebra Cuyún-Carter and Steve Millen and Mariko Nomoto and Yoshie Onishi and Aki Kudo and Pieter Drost and Naoko Sugiyama and Tom Kanazawa Tang and Naoki Niikura},
year = {2026},
journal = {Breast Cancer},
doi = {10.1007/s12282-026-01834-7},
url = {https://doi.org/10.1007/s12282-026-01834-7}
}RIS
TY - JOUR TI - Cost-effectiveness analysis of the Oncotype DX Breast Recurrence Score® test among node-negative early breast cancer patients in Japan AU - Kei Koizumi AU - Ataru Igarashi AU - Mark Gouldson AU - Sandeep Bilthare AU - Sebastien Eymere AU - Gebra Cuyún-Carter AU - Steve Millen AU - Mariko Nomoto AU - Yoshie Onishi AU - Aki Kudo AU - Pieter Drost AU - Naoko Sugiyama AU - Tom Kanazawa Tang AU - Naoki Niikura PY - 2026 JO - Breast Cancer DO - 10.1007/s12282-026-01834-7 UR - https://doi.org/10.1007/s12282-026-01834-7 ER -
APA
Koizumi, K., Igarashi, A., Gouldson, M., Bilthare, S., Eymere, S., Cuyún-Carter, G., Millen, S., Nomoto, M., Onishi, Y., Kudo, A., Drost, P., Sugiyama, N., Tang, T. K., & Niikura, N. (2026). Cost-effectiveness analysis of the Oncotype DX Breast Recurrence Score® test among node-negative early breast cancer patients in Japan. Breast Cancer. https://doi.org/10.1007/s12282-026-01834-7
Source records
- crossref · retrieved 2026-09-27T01:11:22.380Z